Searched for
ALKEM LABORATORIES TARGET PRICE
Nomura raises Adani Ports share price target by 12%. Here are 3 major reasons whyNomura has raised its target price on Adani Ports and Special Economic Zone to Rs 2,080 from Rs 1,850, while retaining its Buy rating. The ...
RIL shares jump 6% in 3 days, market cap soars by Rs 1 lakh cr ahead of AGM. Why Morgan Stanley still sees 38% upsideReliance Industries has added over Rs 1 lakh crore in market value in just three trading sessions ahead of its closely watched AGM. Despite...
Suzlon Energy shares jump over 6%. Why brokerages call it India’s most investible wind energy stock?Suzlon Energy shares rose sharply on Tuesday after the company outlined an ambitious FY31 roadmap focused on expanding beyond wind energy i...
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...
Stock Radar: MRPL bounces back after forming double bottom formation; stock still down 25% from highs – should you buy?Mangalore Refinery and Petrochemicals Ltd stock is showing positive signals. A double bottom formation on daily charts indicates a potentia...
Akal Takht declares Bhagwant Mann 'Anti-Guru', summons CabinetAkal Takht clergy has declared Punjab Chief Minister Bhagwant Mann a 'Guru Dokhi' and 'Khalsa Panth Virodhi'. This action follows accusatio...
DRDO successfully conducts flight-test of Long Range Land Attack Cruise MissileIndia's Defence Research and Development Organisation has successfully tested its indigenously developed Long Range Land Attack Cruise Miss...
Buy, Sell or Hold: RIL remains Morgan Stanley's top pick; remains underweight on Oil IndiaBrokerages remain selective on India's energy sector, favouring companies with strong growth drivers and attractive valuations. Morgan Stan...
Stock Radar: Nestle India stock gives a breakout from a falling channel trendline; time to buy?Nestle India Ltd has broken out of a falling channel resistance on daily charts, signaling potential for further gains. Experts suggest sho...
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 26%On Thursday evening, US President Trump said he would “hit Iran hard tonight”. Then, as the world waited with bated breath, came the announ...
Nestlé India rejects infestation allegations involving MAGGI noodlesNestlé India has denied claims of infestation in Maggi noodles circulating online. The company states that tests on product samples confirm...
PL Capital cuts Nifty target to 26,449, lists 16 high conviction stock picksAmidst global market turmoil from the Iran-US war and El Nino, PL Capital lowered its Nifty 50 target to 26,449. The brokerage anticipates ...
Honasa shares jump 6% on Rs 5,500 crore revenue target by FY31. What is Goldman Sachs saying?Honasa Consumer shares surged after the company outlined a revenue target of ₹5,500 crore by FY31. The guidance implies an annual growth ra...
Two Trades for Today: A top technology supplier for a 5.75% upmove, a mid-cap pharma stock for a 7% riseOur technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
Stock picks of the week; 5 stocks with consistent score improvement and upside potential of up to 25%Even in normal times it is futile to try and guess the outcome of most global events. But in the New World Order, it makes no sense at all ...
UBS downgrades BHEL shares to Neutral from Buy. Check target, key reasonsUBS has downgraded BHEL to "Neutral" from "Buy", citing a more balanced risk-reward outlook after the stock's strong run, though it raised ...
Alkem Labs shares in focus as Goldman, Morgan Stanley, others purchase stake in Rs 930-crore block dealShares of Alkem Laboratories will be in focus after block deals worth around Rs 930 crore saw 17.88 lakh shares traded at Rs 5,200 apiece o...
Stocks in news: Alkem Labs, Vedanta, Canara Bank, NHPC, Adani PortsMarkets closed higher on weekly expiry day despite volatility, with Nifty showing signs of recovery but facing resistance around 23,800-24,...
Alkem Labs sees Rs 930 crore block deal as promoter family entities pare stake; Goldman, Morgan Stanley among key buyersAlkem Laboratories shares experienced significant block deals totaling Rs 930 crore. Promoter family entities divested shares to a group of...
Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight lossAlkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...